Malaria recent guidelines who 2015 & indian 2014
-
Upload
kiran-bikkad -
Category
Health & Medicine
-
view
1.232 -
download
2
Transcript of Malaria recent guidelines who 2015 & indian 2014
![Page 1: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/1.jpg)
MALARIA RECENT
GUIDELINESWHO-2015
By Dr. Kiran BikkadDNB Medicine Resident
Nazareth Hospital, Shillong
![Page 2: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/2.jpg)
Malaria is one of the major public health problems of the country.
India reports around one million malaria cases annually.
![Page 3: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/3.jpg)
In India, P. falciparum and P. vivax are the most common species causing malaria, their proportion being around 50% each.
Plasmodium vivax is more prevalent in the plain areas
P. falciparum predominates in forested and hilly areas.
![Page 4: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/4.jpg)
LIFE CYCLE
![Page 5: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/5.jpg)
In the past, chloroquine was effective for treating nearly all cases of malaria.
In recent studies, chloroquine-resistant P. falciparum malaria has been increasing across the country.
![Page 6: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/6.jpg)
CLINICAL FEATURES Fever - cardinal symptom. chills and rigors. accompanied by headache, myalgia,
arthralgia, anorexia, nausea & vomiting. The symptoms -- non-specific and mimic
viral infections, enteric fever, etc. Malaria suspected in patients in
endemic areas or recently visited endemic area & presenting with above symptoms.
![Page 7: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/7.jpg)
Other causes of fever suspected and investigated in the presence of symptoms like running nose, cough and other signs of
respiratory infection diarrhoea/dysentery burning micturition, lower abdominal pain skin rash/infections, abscess painful swelling of joints ear discharge, lymphadenopathy, etc.
All clinically suspected malaria cases should be investigated by microscopy and/or RDT
![Page 8: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/8.jpg)
EARLY DIAGNOSIS AND COMPLETE TREATMENT OF MALARIA AIMS AT:
● Complete cure● Prevention of progression of
uncomplicated malaria to severe disease
● Prevention of deaths● Interruption of transmission● Minimizing risk of selection and spread
of drug resistant parasites
![Page 9: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/9.jpg)
DIAGNOSIS
1 . Microscopy thick and thin blood gold standard for confirmation of
diagnosis of malaria Advantages :
1. Sensitivity is high. It is possible to detect malaria parasites at
low densities2. To quantify the parasite load.3. To distinguish different species of
malaria parasites and their different stages.
![Page 10: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/10.jpg)
2 . Rapid Diagnostic Test Based on the detection of circulating
parasite antigens. Several types of RDTs are available. Some of them can only detect
P.falciparum, while others can detect other parasite species also.
NVBDCP has recently rolled out bivalent RDTs for detecting P. falciparum and P. vivax
![Page 11: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/11.jpg)
Pf HRP-2 based kits may show positive result up to three weeks after successful treatment and parasite clearance
![Page 12: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/12.jpg)
TREATMENT PRINCIPLES1. Early diagnosis & prompt effective
treatment2. Rational use of antimalarial agents3. Use of combination therapy4. Appropriate weight based dosing
![Page 13: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/13.jpg)
TREATMENT OF UNCOMPLICATED MALARIAP. vivax chloroquine 25 mg/kg. In some patients ( 8 - 30%) relapse due to
hypnozoites in liver cells Relapse prevention, primaquine 0.25
mg/kg daily for 14 days under supervision
![Page 14: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/14.jpg)
CHLOROQUINE & PRIMAQUINE REGIMEN
![Page 15: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/15.jpg)
Primaquine is contraindicated in pregnant women, infants and known G6PD deficient patients.
Primaquine can lead to hemolysis in G6PD deficiency Patient should be advised to
stop primaquine immediately if any of the following symptoms: (i) dark coloured urine (ii) yellow conjunctiva (iii) bluish discolouration of lips (iv) abdominal pain (v) nausea (vi) vomiting (vii) breathlessness, etc.
![Page 16: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/16.jpg)
TREATMENT OF UNCOMPLICATED MALARIAP. falciparum ACT
Artemisinin derivative with long acting antimalarial (amodiaquine, lumefantrine, mefloquine, piperaquine
or sulfadoxine-pyrimethamine). The ACT in the National Programme all over India
except northeastern states is Artesunate (4 mg/kg body weight) daily for 3 days Sulfadoxine (25 mg/kg body weight) & Pyrimethamine (1.25 mg/kg body weight) [AS+SP]
on Day 0.
primaquine (0.75 mg/kg) single dose on Day 2
![Page 17: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/17.jpg)
![Page 18: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/18.jpg)
NORTHEASTERN STATESArunachal Pradesh, Assam, Manipur,
Meghalaya, Mizoram, Nagaland, Tripura
due to late treatment failures to AS+SP in P. falciparum, the presently recommended ACT in national drug policy is a FDC of Artemether-lumefantrine (AL)
ACT used in the national programmeNE states = ALRest of India = AS+SP
![Page 19: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/19.jpg)
MONOTHERAPY OF ORAL ARTEMISININ DERIVATIVES IS BANNED IN INDIA
Injectable artemisinin derivatives should be used only in severe malaria.
![Page 20: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/20.jpg)
TREATMENT OF MALARIA IN PREGNANCY
The ACT should be given for treatment of P. falciparum malaria in second and third trimesters of pregnancy
Quinine recommended in the first trimester.
Plasmodium vivax malaria can be treated with chloroquine.
![Page 21: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/21.jpg)
TREATMENT OF MIXED INFECTIONS
Mixed infections with P. falciparum should be treated as falciparum malaria.
Since AS+SP is not effective in vivax malaria, other ACT should be used.
Anti-relapse treatment with primaquine can for 14 days.
![Page 22: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/22.jpg)
TREATMENT BASED ON CLINICAL CRITERIA WITHOUT LABORATORYCONFIRMATION
If RDT for only P. falciparum is used, negative cases showing signs and symptoms of malaria without other obvious cause for fever called as clinical malaria.
Treatment:- chloroquine 25 mg/kg for 3 days
![Page 23: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/23.jpg)
GENERAL RECOMMENDATIONS FOR THE MANAGEMENT OFUNCOMPLICATED MALARIA1. Avoid starting treatment on empty stomach. 2. The first dose is given under observation.3. Dose repeated if vomiting within half hour of
drug intake.4. Patient asked to report back, if no
improvement after 48 hours/deteriorates.5. Investigate for concomittant illnesses
![Page 24: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/24.jpg)
![Page 25: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/25.jpg)
![Page 26: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/26.jpg)
TREATMENT FAILURE/DRUG RESISTANCE
Patient is called cured, if no fever or parasitaemia till Day 28 after treatment.
Patients may not respond to treatment due to 1)drug resistance/ 2)treatment failure.
Early treatment failure (ETF): Development of danger signs on Day 1, 2 or 3 + parasitaemia higher on Day 2
![Page 27: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/27.jpg)
TREATMENT FAILURE/DRUG RESISTANCE
Late clinical failure (LCF): Development of danger signs + parasitaemia on Day 4 - 28
Late parasitological failure (LPF): parasitaemia on Day 7 - 28 + temperature <37.5°C + did not meet criteria of early treatment failure or late clinical failure.
TREATMENT :- ACT or quinine with Doxycycline.
Doxycycline is contraindicated in pregnancy, lactation and in children up to 8 years.
![Page 28: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/28.jpg)
SEVERE FALCIPARUM MALARIADEFINITION:-one / more of the following, occuring in the absence of an identified alternative cause and in the presence of P. falciparum asexual parasitaemia. Impaired consciousness: GCS<11 in
adults Prostration: Generalized weakness &
unable to sit, stand, walk Multiple convulsions: More than two
episodes within 24hrs
![Page 29: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/29.jpg)
Acidosis:A base deficit of >8 mEq/L or bicarbonate level of <15 mmol/L or plasma lactate>=5mmol/L. respiratory distress
Hypoglycaemia: RBS<40mg/dL Severe Malarial anaemia: HB <5,
haematocrit <15%
![Page 30: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/30.jpg)
Renal impairment: creatinine>3mg/dl blood urea>20mmol/L
Jaundice: Sr bilirubin >3mg/dL with a parasite count >1,00 000/µL
Pulmonary oedema: Radiologically confirmed oxygen saturation<92% on room air respiratory rate>30/min with chest indrawing crepitations on auscultation
Significant bleeding: recurrent / prolonged bleeding from the nose, gums or
venepuncture sites, haematemesis or melaena.
![Page 31: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/31.jpg)
Shock: capillary refill>3sec & systolic blood pressure<80mm Hg, with evidence of impaired perfusion(cool peripheries or prolonged capillary refill).
Hyperparasitaemia: P. falciparum parasitaemia>10%
![Page 32: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/32.jpg)
SEVERE MALARIACLINICAL FEATURES SUMMARY● Impaired consciousness/coma● Convulsions● Renal failure (Sr Creatinine >3 mg/dl)● Jaundice (Sr Bilirubin >3 mg/dl)● Severe anaemia (Hb <5 g/dl)● Pulmonary edema/ARDS● Hypoglycaemia (Plasma Glucose <40
mg/dl)
![Page 33: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/33.jpg)
SEVERE MALARIACLINICAL FEATURES SUMMARY● Metabolic acidosis● Circulatory collapse/shock (SBP <80
mmHg)● Abnormal bleeding● Haemoglobinuria● Hyperpyrexia (Temperature >106°F or
>42°C)● Hyperparasitaemia (>5% parasitized
RBCs ) indian guidelines
![Page 34: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/34.jpg)
SEVERE MALARIA TREATMENTThings Necessary In a care centre:
● Parenteral antimalarials, antipyretics, antibiotics, anticonvulsants● Intravenous infusion facilities● Special nursing for coma patients ● Blood transfusion● Laboratory facilities● Facility for Oxygen, dialysis, ventilator, etc.
![Page 35: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/35.jpg)
SEVERE MALARIA TREATMENT Severe manifestations can develop in P.
falciparum infection over time span as short as 12–24 hours
Parenteral artemisinin derivatives or quinine used as specific antimalarial therapy.
Artesunate: 2.4 mg/kg i.v. or i.m. onadmission 0 hour then at 12 & 24 hours, then once a day (dilute artesunate in 5% Sodium bicarbonate)
![Page 36: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/36.jpg)
Quinine: 20 mg/kg on admission(i.v. infusion in 5% dextrose over 4 hours)
maintenance dose :- 10 mg/kg 8 hourly. beyond 48 hours:- 7 mg/kg 8 hourly
NEVER GIVE BOLUS INJECTION
Artemether: 3.2 mg/kg i.m. given on admission then 1.6 mg/kg per day.
Arteether: 150 mg daily i.m. for 3 days in adults only.
![Page 37: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/37.jpg)
ACT containing mefloquine avoided in cerebral malaria due to neuropsychiatric complications.
Severe malaria due to P. vivax It should be treated like severe P.
falciparum malaria
![Page 38: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/38.jpg)
MANAGEMENT OF COMPLICATIONS
Manifestation or complication
Immediate management
Coma(Cerebral malaria)
Maintain airway, place patient on his or her side, exclude other treatable causes of coma(e.g. hypoglycaemia, bacterial meningitis); avoid harmful ancillary treatments, intubate if necessary.
Hyperpyexia Administer tepid sponging, fanning a cooling blanket and paracetamol
Convulsions Maintain airways; treat promptly with intravenous or rectal diazepam, lorazepam, midazolam or intramuscular paraldehyde. Check blood glucose.
Hypoglycaemia Check blood glucose, correct hypoglycemia and maintain with glucose-containing infusion. Although hypoglycaemia is defined as glucose <2.2mmol/L, the threshold for intervention is <3mmol/L for children <5 years and <2.2 mmol/L for older children and adults.
![Page 39: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/39.jpg)
CONTINUED…Severe anaemia Transfuse with screened fresh
whole blood.Acute Pulmonary edema
Prop patient up at an angle of 45◦, give oxygen, give a diuretic, stop intravenous fluids, intubate and add positive end-expiratory pressure or continuous positive airway pressure in life-threatening hypoxaemia.
Acute kidney injury Exclude pre-renal causes, check fluid balance and urinary sodium, if in established renal failure, add haemofiltration or haemodialysis, or if not available, peritoneal dialysis.
Spontaneous bleeding and coagulopathy
Transfuse with screened fresh whole blood (cryoprecipitate, fresh frozen plasma and platelets, if available); give vitamin K injection
![Page 40: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/40.jpg)
CONTINUED…Metabolic acidosis
Exclude or treat hypoglycaemia, hypovalaemia and septicaemia. If severe, add haemofiltration or haemodialsis.
Shock Suspect septicaemia, take blood for cultures; give parenteral broad-spectrum antimicrobials, correct haemodynamic disturbances.
![Page 41: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/41.jpg)
CHEMOPROPHYLAXIS
For :- TravellersMigrantLabourersMilitary personelExposed to malaria in highly endemic areas
![Page 42: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/42.jpg)
CHEMOPROPHYLAXIS
Short-term (< 6 weeks) Doxycycline: 100 mg/day started 2 days before travel till 4 weeks after
leaving area. contraindicated in pregnant and lactating Women
& children less than 8 years.
Long-term (> 6 weeks) Mefloquine: 5 mg/kg (max 250 mg) weekly and 2 weeks before & 4 weeks after leaving the area. contraindicated with H/O convulsions,
neuropsychiatric problems.
![Page 43: Malaria recent guidelines who 2015 & indian 2014](https://reader034.fdocuments.us/reader034/viewer/2022050614/588879261a28ab34788b5f13/html5/thumbnails/43.jpg)
THANK YOU